Rapport Therapeutics Inc
(RAPP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,790 | -22,669 | -34,786 | -21,267 | -12,558 |
| Depreciation Amortization | -1,447 | -826 | 37 | 59 | 36 |
| Accounts payable and accrued liabilities | -1,040 | -1,134 | N/A | 131 | -502 |
| Other Working Capital | -3,280 | -3,157 | 2,652 | 708 | -1,576 |
| Other Operating Activity | 12,590 | 10,171 | 4,916 | 3,545 | 3,200 |
| Operating Cash Flow | $-33,967 | $-17,615 | $-27,181 | $-16,824 | $-11,400 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -146,991 | -40,854 | N/A | N/A | N/A |
| PPE Investments | -2,039 | -1,072 | -1,636 | -199 | -147 |
| Other Investing Activity | 0 | 0 | -77,224 | 0 | 0 |
| Investing Cash Flow | $-149,030 | $-41,926 | $-78,860 | $-199 | $-147 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 159,099 | N/A | N/A | 54 | 54 |
| Common Stock Repurchased | N/A | N/A | N/A | -4 | N/A |
| Other Financing Activity | 63,913 | 63,659 | 145,136 | 145,226 | 59,862 |
| Financing Cash Flow | $223,012 | $63,659 | $145,136 | $145,276 | $59,916 |
| Beginning Cash Position | 70,254 | 70,254 | 31,159 | 31,159 | 31,159 |
| End Cash Position | 110,269 | 74,372 | 70,254 | 159,412 | 79,528 |
| Net Cash Flow | $40,015 | $4,118 | $39,095 | $128,253 | $48,369 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,967 | -17,615 | -27,181 | -16,824 | -11,400 |
| Capital Expenditure | -2,039 | -1,072 | N/A | -199 | -147 |
| Free Cash Flow | -36,006 | -18,687 | -27,181 | -17,023 | -11,547 |